Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative methylprednisolone, morphine sulfate, and bupivacaine for post-discectomy pain
IRCT20210815052193N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- May 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of methylprednisolone, morphine and bupivacaine in postoperative pain (5 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Pain after surgery and Number of needed intravenous opioids. Started May 2022; status: completed.
02
Drugs
methylprednisolonemorphinebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20210815052193N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210815052193N1.